Stay updated on Sitravatinib Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Sitravatinib Combo in Advanced NSCLC Clinical Trial page
- Check2 days agoChange Detected- Deployed version v3.4.2, replacing v3.4.1. - No visible changes to core study details, eligibility criteria, or results data.SummaryDifference0.1%

- Check10 days agoChange DetectedA revision entry updated from v3.4.0 to v3.4.1, with no substantive content changes indicated. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check31 days agoChange DetectedRevision: v3.3.4 is shown; no observable updates to study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedThe Locations section now includes Connecticut as a site. The HHS Vulnerability Disclosure and Connecticut Locations entry were removed, and the page revision updated to v3.3.3.SummaryDifference0.2%

- Check81 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.1%

Stay in the know with updates to Sitravatinib Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo in Advanced NSCLC Clinical Trial page.